Application 079213

Type
ANDA
Sponsor
ZYDUS PHARMS USA INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001IRBESARTANIRBESARTANTABLET;ORAL75MGNoNo
002IRBESARTANIRBESARTANTABLET;ORAL150MGNoNo
003IRBESARTANIRBESARTANTABLET;ORAL300MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
68382-299IrbesartanIrbesartanZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-299IrbesartanIrbesartanZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-299IrbesartanIrbesartanZydus Pharmaceuticals USA Inc.ANDACurrent
68382-300IrbesartanIrbesartanZydus Pharmaceuticals USA Inc.ANDACurrent
68382-300IrbesartanIrbesartanZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-300IrbesartanIrbesartanZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-301IrbesartanIrbesartanZydus Pharmaceuticals USA Inc.ANDACurrent
68382-301IrbesartanIrbesartanZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-301IrbesartanIrbesartanZydus Pharmaceuticals (USA) Inc.ANDACurrent
70771-1159IrbesartanIrbesartanCadila Healthcare LimitedANDACurrent
70771-1159IrbesartanIrbesartanCadila Healthcare LimitedANDACurrent
70771-1159IrbesartanIrbesartanCadila Healthcare LimitedANDACurrent
70771-1159IrbesartanIrbesartanZydus Lifesciences LimitedANDACurrent
70771-1160IrbesartanIrbesartanZydus Lifesciences LimitedANDACurrent
70771-1160IrbesartanIrbesartanCadila Healthcare LimitedANDACurrent
70771-1160IrbesartanIrbesartanCadila Healthcare LimitedANDACurrent
70771-1160IrbesartanIrbesartanCadila Healthcare LimitedANDACurrent
70771-1161IrbesartanIrbesartanZydus Lifesciences LimitedANDACurrent
70771-1161IrbesartanIrbesartanCadila Healthcare LimitedANDACurrent
70771-1161IrbesartanIrbesartanCadila Healthcare LimitedANDACurrent
70771-1161IrbesartanIrbesartanCadila Healthcare LimitedANDACurrent